GO
Loading...

Bristol-Myers Squibb Co

More

  • Midday Glance: Pharmaceuticals companies Friday, 1 Aug 2014 | 1:35 PM ET

    Baxter International Inc. rose$. 38 or. 5 percent, to $75.07. Bristol-Myers Squibb Co. fell$. 73 or 1.4 percent, to $49.89. Hospira fell$. 88 or 1.6 percent, to $54.59.

  • Early Glance: Pharmaceuticals companies Friday, 1 Aug 2014 | 11:08 AM ET

    Baxter International Inc. rose$. 70 or. 9 percent, to $75.39. Bristol-Myers Squibb Co. rose$. 15 or. 3 percent, to $50.77. Hospira rose$. 49 or. 9 percent, to $55.96.

  • Final Glance: Pharmaceuticals companies Thursday, 31 Jul 2014 | 6:04 PM ET

    Baxter International Inc. fell $1.40 or 1.8 percent, to $74.69. Bristol-Myers Squibb Co. fell$. 50 or 1.0 percent, to $50.62. Hospira fell$. 74 or 1.3 percent, to $55.47.

  • AstraZeneca steps up push into cancer immunotherapy Thursday, 31 Jul 2014 | 8:51 AM ET

    LONDON, July 31- AstraZeneca is accelerating its push into cancer immunotherapy, with plans to test a key experimental drug in new tumor types. AstraZeneca said it would present further data looking at MEDI4736 in lung cancer, as well as early results for head and neck cancer, in September at the annual meeting of the European Society for Medical Oncology.

  • Final Glance: Pharmaceuticals companies Wednesday, 30 Jul 2014 | 6:02 PM ET

    Baxter International Inc. fell$. 25 or. 3 percent, to $76.09. Bristol-Myers Squibb Co. rose$. 11 or. 2 percent, to $51.12. Hospira rose $4.31 or 8.3 percent, to $56.21.

  • Midday Glance: Pharmaceuticals companies Wednesday, 30 Jul 2014 | 1:22 PM ET

    Baxter International Inc. rose$. 07 or. 1 percent, to $76.41. Bristol-Myers Squibb Co. fell$. 03 or. 1 percent, to $50.98. Hospira rose $4.08 or 7.9 percent, to $55.98.

  • Early Glance: Pharmaceuticals companies Wednesday, 30 Jul 2014 | 10:42 AM ET

    Baxter International Inc. rose$. 54 or. 7 percent, to $76.88. Bristol-Myers Squibb Co. fell$. 29 or. 6 percent, to $50.73. Hospira rose $2.11 or 4.1 percent, to $54.01.

  • Final Glance: Pharmaceuticals companies Monday, 28 Jul 2014 | 6:04 PM ET

    Baxter International Inc. fell$. 18 or. 2 percent, to $76.47. Bristol-Myers Squibb Co. rose$. 41 or. 8 percent, to $49.80. Hospira rose$. 12 or. 2 percent, to $51.84.

  • Midday Glance: Pharmaceuticals companies Monday, 28 Jul 2014 | 1:31 PM ET

    Baxter International Inc. fell$. 28 or. 4 percent, to $76.38. Bristol-Myers Squibb Co. rose$. 02 or percent, to $49.41. Hospira rose $1.03 or 2.0 percent, to $52.75.

  • Early Glance: Pharmaceuticals companies Monday, 28 Jul 2014 | 10:33 AM ET

    Baxter International Inc. fell$. 10 or. 1 percent, to $76.55. Bristol-Myers Squibb Co. fell$. 21 or. 4 percent, to $49.18. Hospira rose $2.43 or 4.7 percent, to $54.15.

  • NEW YORK, July 28- Pfizer Inc's vulnerability to cheaper generics and its weak roster of experimental medicines will be on display Tuesday when the company reports quarterly earnings, reviving interest in its pursuit of AstraZeneca Plc or other deals to fortify its pipeline.

  • Final Glance: Pharmaceuticals companies Thursday, 24 Jul 2014 | 6:22 PM ET

    Baxter International Inc. rose$. 16 or. 2 percent, to $77.00. Bristol-Myers Squibb Co. rose$. 14 or. 3 percent, to $49.46. Hospira rose $1.16 or 2.3 percent, to $51.82.

  • July 24- Bristol-Myers Squibb Co reported better-than-expected quarterly results, helped by cost controls and strong sales of its Eliquis blood clot preventer and Yervoy treatment for melanoma. Sales of Eliquis, which Bristol-Myers co-markets with Pfizer Inc, rose to $171 million.

  • Midday Glance: Pharmaceuticals companies Thursday, 24 Jul 2014 | 1:23 PM ET

    Baxter International Inc. rose$. 20 or. 3 percent, to $77.04. Bristol-Myers Squibb Co. rose$. 20 or. 4 percent, to $49.52. Hospira rose$. 74 or 1.5 percent, to $51.40.

  • Early Glance: Pharmaceuticals companies Thursday, 24 Jul 2014 | 11:37 AM ET

    Baxter International Inc. fell$. 13 or. 2 percent, to $76.71. Bristol-Myers Squibb Co. fell$. 16 or. 3 percent, to $49.16. Hospira rose$. 03 or. 1 percent, to $50.69.

  • NEW YORK, July 24- Major global stock markets edged higher while the euro rose from an eight-month low against the U.S. dollar on Thursday following upbeat euro zone data and stronger-than-expected U.S. earnings.

  • Bristol 2Q net drops on lower drug sales, charges Thursday, 24 Jul 2014 | 7:42 AM ET

    NEW YORK— Bristol-Myers Squibb Co.' s exit from the diabetes business, plus higher taxes and research spending, combined to slash the drugmaker's second-quarter profit by 38 percent, but the company handily beat Wall Street's muted profit expectations.

  • Final Glance: Pharmaceuticals companies Tuesday, 22 Jul 2014 | 6:02 PM ET

    Baxter International Inc. rose$. 76 or 1.0 percent, to $76.87. Bristol-Myers Squibb Co. rose$. 20 or. 4 percent, to $49.12. Hospira rose$. 31 or. 6 percent, to $50.78.

  • Midday Glance: Pharmaceuticals companies Tuesday, 22 Jul 2014 | 1:57 PM ET

    Baxter International Inc. rose$. 93 or 1.2 percent, to $77.04. Bristol-Myers Squibb Co. rose$. 41 or. 8 percent, to $49.33. Hospira rose$. 27 or. 5 percent, to $50.74.

  • Early Glance: Pharmaceuticals companies Monday, 21 Jul 2014 | 11:37 AM ET

    Baxter International Inc. fell$. 37 or. 5 percent, to $76.15. Bristol-Myers Squibb Co. fell$. 28 or. 6 percent, to $48.84. Hospira fell$. 06 or. 1 percent, to $50.09.